77 signals · bluesky, h1b_lca, osha +1 more
Scores are directional signals derived from aggregated public data — not verified findings or investment advice. Methodology
Signal-based estimates from public data — not verified assessments. Learn more
Some stress signals present but below significant thresholds.
Low risk signals — no significant operational or reputational pressure detected.
AbbVie exhibits mixed signals with regulatory scrutiny and price target upgrades amid active skilled hiring and workplace safety inspection activity.
Patterns indicate AbbVie is navigating moderate operational stress and low risk, with signals suggesting a blend of financial optimism from analyst price target increases and regulatory/legal headwinds. While hiring activity and price target revisions point to growth confidence, ongoing legal settlements and workplace safety inspections introduce hedges against near-term stability. Confidence in these observations remains high due to direct, verifiable data sources.
If you watched the "MLB Wild Card Series **presented by AbbVie**" you heard or saw that brand hundreds of times. In 2022, AbbVie settled thousands of lawsuits totaling over $2B accusing them of illegally marketing its opioids by downplaying their risks and failing to divert them from the streets.
In 2022, AbbVie settled thousands of lawsuits totaling over $2B accusing them of illegally marketing its opioids by downplaying their risks and failing to divert them from the streets.
AbbVie price target raised to $305 from $289 at BofA TipRanks
Research-based biopharmaceutical company.
Based on 77 signals across 4 sources · snapshot 12 Oct 2026
Strong: enough recent evidence to trust this score.
Overall community sentiment for AbbVie is positive based on public signals as of 12 Oct 2026.
Based on 77 signals across 4 sources
Scores are directional signals derived from public data — not certified assessments or recommendations. Confidence indicates data coverage, not accuracy. Learn how scores are calculated →
Derived from public sources such as news, filings, and reported events.
What this means
Signals suggest a mixed picture — review the evidence below for context.
AI-generated from public signals — may be incomplete. Based on 5 recent signals.
This summary is generated from publicly available review and signal data. It is intended as an indicative overview only and should not be used as the sole basis for employment, investment, or business decisions. Signal volume and source diversity may limit representativeness.
AI summaries are generated from public signals and may not reflect the full picture.
AbbVie price target raised to $320 from $280 at Scotiabank TipRanks
OSHA (US Dept. of Labor) workplace-safety inspection of ABBVIE INC. in NORTH CHICAGO, IL (opened 2026-06-25).